AAAAAA
Results:
1-7
|
Results: 7
Authors:
Gilboe, IM
Kvien, TK
Husby, G
Citation: Im. Gilboe et al., Disease course in systemic lupus erythematosus: Changes in health status, disease activity, and organ damage after 2 years, J RHEUMATOL, 28(2), 2001, pp. 266-274
Authors:
Gilboe, IM
Kvien, TK
Uhlig, T
Husby, G
Citation: Im. Gilboe et al., Sicca symptoms and secondary Sjogren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables, ANN RHEUM D, 60(12), 2001, pp. 1103-1109
Authors:
Gilboe, IM
Kvien, TK
Haugeberg, G
Husby, G
Citation: Im. Gilboe et al., Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls, ANN RHEUM D, 59(2), 2000, pp. 110-115
Authors:
Jensen, JL
Bergem, HO
Gilboe, IM
Husby, G
Axell, T
Citation: Jl. Jensen et al., Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus, J ORAL PATH, 28(7), 1999, pp. 317-322
Authors:
Gilboe, IM
Kvien, TK
Husby, G
Citation: Im. Gilboe et al., Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls, J RHEUMATOL, 26(8), 1999, pp. 1694-1700
Authors:
Anderson, IF
Helve, T
Hannonen, P
Leirisalo-Repo, M
Gilboe, IM
Nissila, M
Keystone, EC
Kraag, GR
Bjorneboe, O
Chalmers, A
Dovland, H
Mueller, E
Richard, F
Whatmough, I
Schmidt, AG
Kovarik, JM
Citation: If. Anderson et al., Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: A double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics, J RHEUMATOL, 26(3), 1999, pp. 556-562
Authors:
Gilboe, IM
Husby, G
Citation: Im. Gilboe et G. Husby, Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connectivetissue disease, SC J RHEUM, 28(2), 1999, pp. 81-87
Risultati:
1-7
|